"For centuries, indigenous cultures across Mexico and Central America have used Psilocybe mushrooms in their healing ceremonies. Today, those same fungi are being explored as a treatment for psychiatric disorders."
"A 2025 Phase 2 trial found a single 25 mg psilocybin dose improved PTSD symptoms for up to twelve weeks, indicating significant therapeutic potential."
"Psilocybin temporarily 'resets' the Default Mode Network, which is often overactive in conditions like OCD, PTSD, and depression, creating a window of increased neuroplasticity."
"The FDA has granted psilocybin Breakthrough Therapy status for both treatment-resistant and major depression, underscoring its promise in psychiatric treatment."
Indigenous cultures have utilized psilocybin mushrooms for healing for centuries. Recent studies indicate that psilocybin may effectively treat psychiatric disorders like OCD, PTSD, and major depression. A Phase 2 trial in 2025 demonstrated that a single 25 mg dose of psilocybin significantly improved PTSD symptoms for up to twelve weeks. The FDA has recognized psilocybin as a Breakthrough Therapy for treatment-resistant and major depression, highlighting its potential as a prescription medicine for challenging psychiatric conditions.
Read at Psychology Today
Unable to calculate read time
Collection
[
|
...
]